CSIMarket Company Name, Ticker, Competitors, else..
 
Qiagen N v   (NYSE: QGEN)
Other Ticker:  
 
 

Qiagen N V Growth Comparisons

Select each growth Category to receive further Information




 
QGEN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 0.98 % -2.05 % 6.56 % 5.68 %
Q / Q Revenue Growth (Q4 MRQ) - 0.17 % 2.01 % 2.64 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 0.98 % 5.11 % 5.04 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) - -0.69 % 1.28 % 1.73 %
Revenue 5 Year Average Growth 5.03 % 6.38 % 8.2 % 7.6 %


QGEN's Growth Comparisons in IV. Quarter 2024




Qiagen N V managed to grow Revenue by 0.98% year on year, in the forth quarter 2024 to 1.92 billions, while Biotechnology & Pharmaceuticals industry fell by -2.05%, Healthcare sector grew 6.56%.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by 5.03% on average in last five years, while S & P 500's including only Businesses with the forth quarter 2024 earnings reports, average yearly sales growth is 7.6%.

QGEN Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Molecular Diagnostics
-
-
Life Sciences
-
-
Consumables and related Molecular Diagnostics
-
-
Consumables and related Life Sciences
-
-
Instruments Molecular Diagnostics
-
-
Instruments Life Sciences
-
-
Sample technologies
-
-
Diagnostic solutions
-
-
PCR Nucleic acid amplification
-
-
Genomics NGS
-
-
Other
-
-
Reportable Segment
-
-
Netherlands
-
-
Total Americas
-
-
United States
-
-
Other Americas
-
-
Europe Middle East and Africa
-
-
Asia Pacific Japan and Rest of World
-
-
Total
-
-


Growth Rates of QGEN's Income in the forth quarter 2024


QGEN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) -76.16 % 34.86 % 37.15 % -0.25 %
Sequential Operating Income Change (Q4 MRQ) - 62.8 % -23.6 % -8.72 %
Y / Y Operating Income Growth (Q4 TTM) -76.16 % -71.9 % 20.7 % 9.22 %
Sequential Operating Income Growth (Q4 TTM) -76.16 % 46.28 % 7 % -0.24 %
Operating Income 5 Year Avg. Change -18.19 % - -1.74 % 9.14 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) -75.51 % -75.33 % 28.02 % 22.95 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - -86.45 % -14.66 % 8.12 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) -75.51 % - 25.67 % 11.53 %
Sequential Income from Cont. Ops. Change (Q4 TTM) -75.51 % - -0.87 % 4.54 %
Income from Cont. Ops. 5 Year Avg. Change -15.18 % - -8.93 % 9.1 %

QGEN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) -75.51 % -75.08 % 29.84 % 25.79 %
Q / Q Net Income Growth (Q4 MRQ) - -86.45 % -20.3 % 7.59 %
Y / Y Net Income Change (Q4 TTM) -75.51 % - -7.73 % 9.64 %
Sequential Net Income Change (Q4 TTM) -75.51 % - -1.12 % 5.13 %
Net Income 5 Year Avg. Growth -15.18 % - -8.52 % 8.66 %

QGEN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) -74.67 % -76.35 % 28.02 % 22.95 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - -86.13 % -14.66 % 8.12 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) -74.67 % - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) -74.67 % - - 33 %
EPS from Cont. Ops. 5 Year Avg. Growth -14.67 % - -8.93 % 9.1 %



QGEN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) -75 % -76.11 % 29.84 % 9.1 %
Q / Q EPS Net Growth (Q4 MRQ) - -86.13 % -20.3 % 7.59 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 92.65 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) -75 % - - 33 %
EPS Net 5 Year Avg. Change - - -8.52 % 8.66 %



With -75% year on year EPS drop in the forth quarter, Qiagen N V 's decline was less than the -76.11% in Biotechnology & Pharmaceuticals industry but underperformed the 29.84% EPS increase in the Healthcare sector. Healthcare sector grew above the market average, while the Biotechnology & Pharmaceuticals industry and Qiagen N V results underperformed, in the forth quarter 2024.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by 5.03% on average in the last five years, while the S & P 500's including only the businesses with the forth quarter 2024 financial results, average yearly income per share growth is 8.66%.

QGEN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) 46.6 % 252.94 % 33.69 % 32.78 %
Sequential Free Cash Flow Change (Q4 MRQ) - 38.66 % -1.87 % 112.49 %
Y / Y Free Cash Flow Change (Q4 TTM) 46.6 % 71.29 % 13.46 % 10.16 %
Sequential Free Cash Flow Change (Q4 TTM) 46.6 % 41.12 % 7.9 % 9.32 %
Free Cash Flow 5 Year Avg. Change 19.2 % -16.98 % 4.78 % 8.3 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - - -81.06 %
Sequential Net Cash Flow Change (Q4 MRQ) - 1624.99 % - -
Y / Y Net Cash Flow Change (Q4 TTM) - 1060.27 % - -
Sequential Net Cash Flow Change (Q4 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - - -16.14 % 0.62 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 5.18 % 34.67 % 6.92 % 22.3 %
Sequential Capital Expenditures Change (Q4 MRQ) - 54.93 % 21.24 % 17.09 %
Y / Y Capital Expenditures Change (Q4 TTM) 5.18 % 3.5 % 3.56 % 41.38 %
Sequential Capital Expenditures Change (Q4 TTM) 5.18 % 10.94 % 1.51 % 6.81 %
Capital Expenditures 5 Year Avg. Change 2.58 % 4.59 % 8.01 % 7.66 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com